Differences in methodology, but not differences in viral strain, account for variable experimental outcomes in laboratories utilizing the cottontail rabbit papillomavirus model
- PMID: 20036285
- PMCID: PMC2845176
- DOI: 10.1016/j.jviromet.2009.12.014
Differences in methodology, but not differences in viral strain, account for variable experimental outcomes in laboratories utilizing the cottontail rabbit papillomavirus model
Abstract
The cottontail rabbit papillomavirus (CRPV) animal model is used in several laboratories worldwide to investigate immunogenicity, carcinogenicity and life cycle aspects of papillomaviruses. It is the only animal model in which the full life cycle of the virus from initiation of infection to malignant progression can be studied. A major strength of the model is that the viral DNA is infectious. This feature allows for the study of mutant genomes without the need to create infectious mutant virus. Results from laboratory to laboratory have not always been consistent. Different laboratories use different methods for creating infections from DNA and it was postulated that the different challenge methods could play a role in the differential outcomes. Because different laboratories use different strains of CRPV, it was also desirable to test if the difference in CRPV genomes contributed to the differential outcomes. In this study, three of the CRPV strains used most widely (Washington B, Orth CRPV and Hershey CRPV) were cloned into PUC19; the E8 ATG ko mutants for each strain were also generated. We employed the infection technique reported previously in which scarification is done first and is followed with delivery of DNA by pipette 3 days later. The papilloma outgrowth generated by these three wild type constructs and their E8 ATG ko mutants was compared. No significant difference was found among the three strains or their E8 ATG ko mutants. E8 ATG ko mutants induced significantly smaller but persistent papillomas when compared to their respective wild type CRPVs. The gene gun was also used to create infections with both Hershey CRPV DNA and the corresponding E8 ATG ko and was found to lead to less vigorous growth as well as some regressions. Further studies suggested that gene gun delivery might have induced an immune response which then resulted in compromised growth of papillomas. It was concluded that the E8 gene is not required for infection. We suggest that standardized infection methods should be used in laboratories so that inconsistencies in conclusions will be minimized.
Copyright (c) 2009 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.Viral Immunol. 2006 Summer;19(3):492-507. doi: 10.1089/vim.2006.19.492. Viral Immunol. 2006. PMID: 16987067
-
Amino acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus E6 influence spontaneous regression of cutaneous papillomas.J Virol. 2002 Dec;76(23):11801-8. doi: 10.1128/jvi.76.23.11801-11808.2002. J Virol. 2002. PMID: 12414922 Free PMC article.
-
Intracutaneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits.J Virol. 2002 Jul;76(13):6453-9. doi: 10.1128/jvi.76.13.6453-6459.2002. J Virol. 2002. PMID: 12050357 Free PMC article.
-
Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies.Antivir Chem Chemother. 2005;16(6):355-62. doi: 10.1177/095632020501600602. Antivir Chem Chemother. 2005. PMID: 16331841 Review.
-
Recent advances in preclinical model systems for papillomaviruses.Virus Res. 2017 Mar 2;231:108-118. doi: 10.1016/j.virusres.2016.12.004. Epub 2016 Dec 9. Virus Res. 2017. PMID: 27956145 Free PMC article. Review.
Cited by
-
Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus.Viruses. 2022 Sep 4;14(9):1964. doi: 10.3390/v14091964. Viruses. 2022. PMID: 36146770 Free PMC article. Review.
-
Characterization of the nuclear matrix targeting sequence (NMTS) of the BPV1 E8/E2 protein--the shortest known NMTS.Nucleus. 2015;6(4):289-300. doi: 10.1080/19491034.2015.1074359. Nucleus. 2015. PMID: 26218798 Free PMC article.
-
Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).J Virol Methods. 2018 Mar;253:11-17. doi: 10.1016/j.jviromet.2017.12.002. Epub 2017 Dec 15. J Virol Methods. 2018. PMID: 29253496 Free PMC article.
-
The rabbit papillomavirus model: a valuable tool to study viral-host interactions.Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180294. doi: 10.1098/rstb.2018.0294. Philos Trans R Soc Lond B Biol Sci. 2019. PMID: 30955485 Free PMC article. Review.
-
Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models.Emerg Microbes Infect. 2019;8(1):1108-1121. doi: 10.1080/22221751.2019.1637072. Emerg Microbes Infect. 2019. PMID: 31340720 Free PMC article.
References
-
- Alvarez D, Harder G, Fattouh R, Sun JF, Goncharova S, Stampfli MR, Coyle AJ, Bramson JL, Jordana M. Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses. Journal of Immunology. 2005;174:1664–1674. - PubMed
-
- Bodily JM, Hoopes DJ, Roeder BL, Gilbert SG, Pettit GR, Herald CL, Rollins DN, Robison RA. The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas. Cancer Lett. 1999;136:67–74. - PubMed
-
- Brandsma JL. The cottontail rabbit papillomavirus model of high-risk HPV-induced disease. Methods Mol.Med. 2005;119:217–235. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials